NI-0501 not checked

Swedish Orphan Biovitrum

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
3 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Primary Haemophagocytic Lymphohistiocytosis, Rare Diseases
Main trialPhase 2/3
“The purpose of this study is to assess the safety, tolerability and efficacy of a new drug aimed at controlling disease activity in patients diagnosed with primary haemophagocytic lymphohistiocytosis. The new drug can be administered as the first-line therapy, to patients not previously treated with the current standard of care, or can be given to patients who have either failed or were unable to tolerate the current standard of care. Administration will be on top of a glucocorticosteroid, which is usually part of the current recommended treatment.”In the company’s words, NCT01818492 on ClinicalTrials.gov
Other names
Gamifant

Other drugs for Rare Diseases

All 10 drugs for Rare Diseases

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 2/3Completed Jan 2019 Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis
Phase 1Completed Jan 2013 First in Human Study of an Anti-IFN Gamma Monoclonal Antibody in Healthy Volunteers
Phase 1Completed 25 Jun 2021 A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow NI-0501

Following is part of Solo: you see every change to NI-0501 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in